These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24983743)

  • 21. Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: an analysis of the implications for perioperative management.
    Mookadam M; Shamoun FE; Ramakrishna H; Obeid H; Rife RL; Mookadam F
    Ann Card Anaesth; 2015; 18(4):517-27. PubMed ID: 26440238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of venous thrombo-embolism: an update.
    Konstantinides S; Torbicki A
    Eur Heart J; 2014 Nov; 35(41):2855-63. PubMed ID: 25179762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Best Clinical Practice: Current Controversies in Pulmonary Embolism Imaging and Treatment of Subsegmental Thromboembolic Disease.
    Long B; Koyfman A
    J Emerg Med; 2017 Feb; 52(2):184-193. PubMed ID: 27720540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic management of acute pulmonary embolism.
    Tromeur C; Van Der Pol LM; Couturaud F; Klok FA; Huisman MV
    Expert Rev Respir Med; 2017 Aug; 11(8):641-648. PubMed ID: 28580827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New anticoagulants in the management of venous thromboembolism in women.
    Piovella F; Irina Iosub D
    Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments.
    Lenchus JD; Biehl M; Cabrera J; Moraes AG; Dezfulian C
    J Intensive Care Med; 2017 Jun; 32(5):299-311. PubMed ID: 27179058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting.
    Jugrin AV; Hösel V; Ustyugova A; De Francesco M; Lamotte M; Sunderland T
    J Med Econ; 2016; 19(1):1-10. PubMed ID: 26390231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of venous thromboembolism.
    Wells PS; Forgie MA; Rodger MA
    JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on pharmacologic therapy for pulmonary embolism.
    Harikrishnan P; Palaniswamy C; Aronow WS
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):159-69. PubMed ID: 24177334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants.
    Rosovsky R; Merli G
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):141-151. PubMed ID: 29029708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
    Kakkos SK; Kirkilesis GI; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
    Leung TS; Law EH
    Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New anticoagulants for treatment of venous thromboembolism.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2012 Dec; 23(8):692-5. PubMed ID: 23095463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Update on Current Care Guideline: Venous thromboembolism (VTE): deep venous thrombosis and pulmonary embolism].
    Duodecim; 2016; 132(7):683-4. PubMed ID: 27188093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism: contemporary diagnostic and therapeutic aspects.
    Bounameaux H; Righini M; Perrier A
    Vasa; 2008 Aug; 37(3):211-26. PubMed ID: 18690588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis, prognosis and therapeutic management of acute pulmonary embolism.
    Tapson VF
    Hosp Pract (1995); 2016 Aug; 44(3):164-72. PubMed ID: 27450108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients.
    Chatterjee S; Sardar P; Giri JS; Ghosh J; Mukherjee D
    Mayo Clin Proc; 2014 Jul; 89(7):896-907. PubMed ID: 24996233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary embolism.
    McRae S
    Aust Fam Physician; 2010 Jul; 39(7):462-6. PubMed ID: 20628658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.